Home > Financial Ratios > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
Core EBITDA Growth

    Back to All Ratios
PAR DRUGS AND CHEMICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results

PAR DRUGS AND CHEMICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -6.1125.0212.211.4669.70

What is the latest Core EBITDA Growth ratio of PAR DRUGS AND CHEMICALS ?

The latest Core EBITDA Growth ratio of PAR DRUGS AND CHEMICALS is -6.11 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-6.11
Mar202425.02
Mar202312.21
Mar20221.46
Mar202169.70

How is Core EBITDA Growth of PAR DRUGS AND CHEMICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -6.11
Negative
Mar2024 25.02
104.91
Mar2023 12.21
736.30
Mar2022 1.46
-97.91
Mar2021 69.7 -

Other Financial Ratios of PAR DRUGS AND CHEMICALS


Compare Core EBITDA Growth ratio of peers of PAR DRUGS AND CHEMICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS ₹130.0 Cr -6.1% -20.8% 7.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹107,528.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.2% 6% -2.4% Stock Analytics


PAR DRUGS AND CHEMICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS

-6.1%

-20.8%

7.2%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses